\documentclass{article}%
\usepackage[T1]{fontenc}%
\usepackage[utf8]{inputenc}%
\usepackage{lmodern}%
\usepackage{textcomp}%
\usepackage{lastpage}%
\usepackage{authblk}%
\usepackage{graphicx}%
%
\title{Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network}%
\author{Angela Holt}%
\affil{Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei, Taiwan, R.O.C., Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan, R.O.C., Research Institute for Children, Children's Hospital, New Orleans, LA, USA}%
\date{01{-}01{-}2014}%
%
\begin{document}%
\normalsize%
\maketitle%
\section{Abstract}%
\label{sec:Abstract}%
Mid Times Disruptors, our series that examines the prevalence of mid{-} and high{-}volume random generator reactions that do not have a consensus personality, publishes our second set of interviews with the participants involved in the project.\newline%
Identifying a controllable dysfunction in sensory systems requires a strategy capable of solving the terrors and challenges that face the human race. This group suggests two models of multi{-}method technology that will analyze the complex interactions between cells in a variety of tissue types.\newline%
VeriPath Genomics, Inc. (VGP), an integrator of sequencing and proteomics, helps expedite the process of designing search algorithms for these specialized circuits. Providing this proof of concept is the laboratory of Dr. Gary Wolstat, Department of Biochemistry and Molecular Biology and part of VGPs research team for the challenging, second generation defibrillator.\newline%
In order to perform this sophisticated profile, the researchers need to gather the facts and determine the affected cell type and organ system that can have the desired contribution. VGPs objective is to collect the data while maintaining the availability of efficiently priced, high resolution heterotome for preclinical testing.\newline%
The companion article on the topic, authored by Dr. Paul Shapiro, Associate Professor of Laboratory Medicine at the Baylor College of Medicine in Houston, Texas, states:\newline%
While the intuition might suggest a trait difference that we notice in a certain segment of a population, there is little data in a population of a given ancestry. Its easy to see how the idiosyncratic differences we see between certain genetic markers (like monotype) or none (like script) can be interpreted for a gene called Fusarium verticillioides (F is for diff)) that represents one of the competing models of regulation for a mammalian nervous system. A review of historical data also shows that F can be seen in almost every species with an unknown variation. Moreover, the interactions among F and other cells are illustrated for any number of species. This article, as well as the sublist of diagnostic tests, certainly has a broad spectrum of results that could be performed in a laboratory as part of a clinical trial. But this approach is especially difficult to design in a situation where it may be difficult to obtain sufficient validation. In this case we propose a multi{-}method target for preclinical validation, one that targets cell identity function in larger proportions than the f in F that would normally occur in response to an epithelial lesion. The current standard is very limited as the required mutations, if any, are extremely hard to identify from data on well{-}known cell types (including autostructure genes). On the other hand, VGPs approach to the F verticillioides is clinically superior to other models, as all studies can be done in larger numbers without affecting the quality of the animals.\newline%
In addition to an understanding of molecular and regulatory status in biological systems, the translational work takes into account patient decision{-}making (while not creating novel disease). The development of an evidence{-}based assessment through clinical trials can be the difference between life and death. This is necessary as the human body has evolved to be resilient to autoplasmic diseases without injury to the nervous system. This work has a bright future as VGPs team has the tools and expertise to assist in the commercialization of such precision medicine. In addition to helping to advance the science for the purpose of discovery and improvement, the work also provides therapeutic benefit in addressing the most common diseases facing patients.

%
\subsection{Image Analysis}%
\label{subsec:ImageAnalysis}%


\begin{figure}[h!]%
\centering%
\includegraphics[width=150px]{500_fake_images/samples_5_12.png}%
\caption{A Close Up Of A Small Bird In A Field}%
\end{figure}

%
\end{document}